Amarin Receives National Reimbursement for VAZKEPA® in Italy
Provided By GlobeNewswire
Last update: Dec 16, 2024
-- Italian Health Authorities Approve VAZKEPA® (icosapent ethyl) for National Reimbursement to Reduce Cardiovascular Risk in Eligible High-Risk Patients1 --
Read more at globenewswire.com
